Calisa Acquisition Corp to Begin Independent Trading of Its Ordinary Shares and Rights
Unit Trading Announcement: Calisa Acquisition Corp will allow holders of its IPO units to separately trade ordinary shares and rights starting November 19, 2025, with trading symbols "ALIS" for shares and "ALISR" for rights on Nasdaq.
Company Background: The Company is a Cayman exempt blank check company aimed at merging or acquiring businesses, focusing primarily on opportunities in Asia.
No Fractional Rights: Upon separation, only whole rights will be issued and traded, while unsplit units will continue to trade under the symbol "ALISU."
Forward-Looking Statements: The press release includes forward-looking statements that are subject to various risks, with no obligation for the Company to update these statements post-release.
Trade with 70% Backtested Accuracy
Analyst Views on ALISU

No data
About the author


Unit Trading Announcement: Calisa Acquisition Corp will allow holders of its IPO units to separately trade ordinary shares and rights starting November 19, 2025, with trading symbols "ALIS" for shares and "ALISR" for rights on Nasdaq.
Company Background: The Company is a Cayman exempt blank check company aimed at merging or acquiring businesses, focusing primarily on opportunities in Asia.
No Fractional Rights: Upon separation, only whole rights will be issued and traded, while unsplit units will continue to trade under the symbol "ALISU."
Forward-Looking Statements: The press release includes forward-looking statements that are subject to various risks, with no obligation for the Company to update these statements post-release.
- IPO Market Performance: The IPO market in July has been slow, with some small issuers joining the calendar. Notable recent IPOs include WEBTOON Entertainment and LandBridge.
- Upcoming IPOs/SPACs: Several companies are expected to be priced this week, including Global Engine Group Holding, Jinxin Technology, Primega Group Holdings, EShallGo, and Majestic Ideal Holdings.
- New Filings: Companies like Solera, DiamiR Biosciences, OneStream, Artiva Biotherapeutics, Cayson Acquisition, and Calisa Acquisition have filed for IPOs with varying deal sizes and focuses.
- Terms and Changes: Safe Pro Group and Lirum Therapeutics have set terms for their IPOs, with SPAI aiming to raise up to $6M and LRTX revising its terms to raise $25M.
- SA Commentary: The article also includes commentary on various aspects of the IPO market and recent developments in specific companies going public.






